Robert Reiter MD

Surgical Oncology

Professor, Urology, UCLA School of Medicine

UCLA Medical Center10833 LeConte Ave, 66-128 CHSLos Angeles, CA 90095
Phone+1 310-794-7224
Fax+1 310-794-7224

Dr. Reiter is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Reiter's full profile Already have an account?

Summary

Dr. Robert Reiter is a Urology specialist with a subspecialty in Surgical Oncology based in Los Angeles, CA. He completed his education and training at Stanford University and Baylor College of Medicine, with expertise in urologic oncology, minimally invasive surgeries, and robotic procedures. Dr. Reiter has contributed to multiple publications on prostate cancer in prestigious journals. He has received honors such as CMS Meaningful Use Certifications and is an elected member of The American Society for Clinical Investigation. Additionally, he has been recognized as a Super Doctor by SuperDoctors.com.

Education & Training

Baylor College of MedicineResidency, Urology, 1990 - 1995
Stanford Health Care-Sponsored Stanford UniversityResidency, Urology, 1989 - 1990
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1988 - 1989
Stanford University School of MedicineClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1989 - 2027
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Elected Member The American Society for Clinical Investigation, 2004

Publications & Presentations

PubMed

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patien...
Amar U Kishan, Yilun Sun, Christopher C Parker, Paul Sargos, Matthew Sydes
European Urology. 2026-07-28
Head-to-head Comparison of Multimodal Imaging for Prostate Cancer Detection and Local Staging with Whole-mount Histopathology Reference.
Qi Miao, Anthony Sisk, Ida Sonni, Kyla Grunden, Vinicius Ludwig
European Urology Oncology. 2026-06-11
1 citations
Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis.
Amar U Kishan, Yilun Sun, Christopher C Parker, Paul Sargos, Matthew R Sydes
Lancet. 2026-03-14

Journal Articles

Near-Infrared-Dye Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models
Robert Reiter, MD, Clinical Cancer Research

Press Mentions

Shorter Radiation Treatment After Surgery Found Safe for Prostate Cancer PatientsMay 14th, 2025
What Everyone Needs to Know About Prostate CancerAugust 26th, 2024
University Receives Prostate Cancer-Fighting GrantOctober 31st, 2019